TAP Files NDA For Prevacid Follow-On To Treat GERD-Related Illnesses
This article was originally published in The Pink Sheet Daily
Executive Summary
Secret of novel delivery system, trial data for TAK-390MR will be revealed at Digestive Disease Week conference in May, TAP VP-Gastrointestinal Marketing Rudolphi tells “The Pink Sheet” DAILY.”
You may also be interested in...
FDA Puts Off Forest’s Fibromyalgia Drug Milnacipran
For unknown reasons, SSNRI spending weeks in regulatory limbo.
FDA Puts Off Forest’s Fibromyalgia Drug Milnacipran
For unknown reasons, SSNRI spending weeks in regulatory limbo.
Takeda Buys Abbott’s Stake In TAP Joint Venture
Japanese pharma establishes Takeda America Holdings, combining all of its U.S. subsidiaries.